ID: ALA316871

Max Phase: Preclinical

Molecular Formula: C19H18N2O5

Molecular Weight: 354.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@@H](Cc1c[nH]c2ccccc12)N1C(=O)[C@@H]2[C@H](C1=O)[C@H]1CC[C@@H]2O1

Standard InChI:  InChI=1S/C19H18N2O5/c22-17-15-13-5-6-14(26-13)16(15)18(23)21(17)12(19(24)25)7-9-8-20-11-4-2-1-3-10(9)11/h1-4,8,12-16,20H,5-7H2,(H,24,25)/t12-,13-,14+,15-,16+/m1/s1

Standard InChI Key:  NXYMCEGDUWHVJR-LJIZCISZSA-N

Associated Targets(Human)

Protein phosphatase 2C beta 71 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Serine-threonine protein phosphatase 2A regulatory subunit 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 354.36Molecular Weight (Monoisotopic): 354.1216AlogP: 1.33#Rotatable Bonds: 4
Polar Surface Area: 99.70Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.79CX Basic pKa: CX LogP: 1.24CX LogD: -2.03
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.81Np Likeness Score: 0.05

References

1. McCluskey A, Walkom C, Bowyer MC, Ackland SP, Gardiner E, Sakoff JA..  (2001)  Cantharimides: a new class of modified cantharidin analogues inhibiting protein phosphatases 1 and 2A.,  11  (22): [PMID:11677131] [10.1016/s0960-894x(01)00594-7]

Source